Overall Cancer Statistics - Annual Report to the Nation
The Annual Report to the Nation on the Status of Cancer has statistics on cancer deaths and new cases (incidence).
NIH study investigates trends in early-onset cancers - NCI
May 8, 2025 · Changes in cancer screening guidelines, advances in imaging technologies, and increased surveillance of high-risk individuals may also have led to earlier cancer diagnoses, …
Surveillance, Epidemiology, and End Results Program
Apr 16, 2025 · An authoritative source for cancer statistics in the US. We collect incidence, prevalence and survival data and publish reports on these and cancer mortality. For those …
PALB2 and Associated Cancer Risks (PDQ®) - NCI
Feb 14, 2025 · Evidence-based, expert-reviewed summary about the PALB2 gene, the cancer risks associated with PALB2, screening, risk-reduction, treatment, and prognosis.
Why Is Early-Onset Cancer On the Rise? - NCI
May 14, 2025 · There is some evidence that inherited cancer-related genetic changes, often called germline mutations, may bear some responsibility for the growing number of early-onset …
CTEP ETCTN - NCI - dctd.cancer.gov
Sep 15, 2025 · View PDFs showing the latest portfolio of CTEP-supported cancer clinical trials open or upcoming in the ETCTN (updated monthly). For full functionality, download and open …
cide.ccr.cancer.gov
Search: Query whether a gene is associated with cancer clinical outcome, integrating a large amount of datasets. Prioritize: Input a gene set and prioritize top candidates for experimental …
SEER Program Coding and Staging Manual
SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable …
Impacts of prevention, screening, treatment on cancer deaths
Dec 5, 2024 · For more information about cancer, please visit the NCI website at cancer.gov or call NCI’s contact center, the Cancer Information Service, at 1-800-4-CANCER (1-800-422-6237).
ures directly from surgical resections of Cancer or Patient-derived xenografts. Please r 90% success rate starting from patient-derived xenograft (PDX)-derived tumors. Important factors …